Works matching IS 14620324 AND DT 2007 AND VI 46 AND IP 12

Results: 30

Psoriatic arthritis is a joint-damaging disease a call for action!

Published in:

Rheumatology, 2007, v. 46, n. 12, p. 1747, doi. 10.1093/rheumatology/kem238

By:

W. J. Taylor;
P. S. Helliwell

Publication type:

Article

The Vitamin D Paradox.

Published in:: Rheumatology, 2007, v. 46, n. 12, p. 1749, doi. 10.1093/rheumatology/kem292
Publication type:: Article

Assessment of outcome in clinical trials of gout a review of current measures.

Published in:

Rheumatology, 2007, v. 46, n. 12, p. 1751, doi. 10.1093/rheumatology/kem178

By:

W. J. Taylor;
H. R. Schumacher;
J. A. Singh;
R. Grainger;
N. Dalbeth

Publication type:

Article

Regulators of cytokine signalling in rheumatoid arthritis.

Published in:: Rheumatology, 2007, v. 46, n. 12, p. 1745, doi. 10.1093/rheumatology/kem285
Publication type:: Article

Effect of annual intramuscular vitamin D on fracture risk in elderly men and women a population-based, randomized, double-blind, placebo-controlled trial.

Published in:

Rheumatology, 2007, v. 46, n. 12, p. 1852, doi. 10.1093/rheumatology/kem240

By:

H. Smith;
F. Anderson;
H. Raphael;
P. Maslin;
S. Crozier;
C. Cooper

Publication type:

Article

Sjogrens Systemic Clinical Activity Index (SCAI) a systemic disease activity measure for use in clinical trials in primary Sjogrens syndrome.

Published in:

Rheumatology, 2007, v. 46, n. 12, p. 1845, doi. 10.1093/rheumatology/kem280

By:

S. J. Bowman;
N. Sutcliffe;
D. A. Isenberg;
F. Goldblatt;
M. Adler;
E. Price;
A. Canavan;
J. Hamburger;
A. Richards;
S. Rauz;
M. Regan;
K. Gadsby;
S. Rigby;
A. Jones;
R. Mathew;
D. Mulherin;
A. Stevenson;
P. Nightingale

Publication type:

Article

Inter-examiner reproducibility of tests and criteria for generalized joint hypermobility and benign joint hypermobility syndrome.

Published in:

Rheumatology, 2007, v. 46, n. 12, p. 1835, doi. 10.1093/rheumatology/kem290

By:

B. Juul-Kristensen;
H. Røgind;
D. V. Jensen;
L. Remvig

Publication type:

Article

Monitoring patients treated with anti-TNF-{alpha} biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies.

Published in:

Rheumatology, 2007, v. 46, n. 12, p. 1828, doi. 10.1093/rheumatology/kem261

By:

M. Svenson;
P. Geborek;
T. Saxne;
K. Bendtzen

Publication type:

Article

Mevalonate kinase deficiency syndrome with structural damage responsive to anakinra.

Published in:

Rheumatology, 2007, v. 46, n. 12, p. 1860, doi. 10.1093/rheumatology/kem258

By:

T. Lequerré;
O. Vittecoq;
S. Pouplin;
N. Klemmer;
O. Mejjad;
A. Daragon;
A. M. Prieur;
X. Le Loët

Publication type:

Article

Comment on: Use of the QuantiFERON-TB(R) Gold test as part of a screening programme in patients with RA under consideration for treatment with anti-TNF-{alpha} agents: the Newcastle (UK) experience: reply.

Published in:

Rheumatology, 2007, v. 46, n. 12, p. 1864, doi. 10.1093/rheumatology/kem256

By:

A. Pratt;
K. Nicholl;
L. Kay

Publication type:

Article

Specialist interventions at the rheumatology outpatient clinic.

Published in:

Rheumatology, 2007, v. 46, n. 12, p. 1859, doi. 10.1093/rheumatology/kem255

By:

M. Wray;
G.D. Wright

Publication type:

Article

Cartilage oligomeric matrix protein in systemic sclerosis.

Published in:

Rheumatology, 2007, v. 46, n. 12, p. 1858, doi. 10.1093/rheumatology/kem254

By:

M. Yamamoto;
H. Takahashi;
C. Suzuki;
Y. Naishiro;
H. Yamamoto;
K. Imai;
Y. Shinomura

Publication type:

Article

Comment on: Use of the QuantiFERON TB Gold test as part of a screening programme in patients with RA under consideration for treatment with anti-TNF-{alpha} agents: the Newcastle (UK) experience.

Published in:

Rheumatology, 2007, v. 46, n. 12, p. 1863, doi. 10.1093/rheumatology/kem252

By:

V. V. Kaushik;
S. Ambalavanan;
K. Binymin

Publication type:

Article

HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis scleroderma overlap.

Published in:

Rheumatology, 2007, v. 46, n. 12, p. 1786, doi. 10.1093/rheumatology/kem265

By:

L. R. Wedderburn;
N. J. McHugh;
H. Chinoy;
R. G. Cooper;
F. Salway;
W. E. R. Ollier;
L. J. McCann;
H. Varsani;
J. Dunphy;
J. North;
J. E. Davidson;
on behalf of the Juvenile Dermatomyositis Research Group (JDRG)

Publication type:

Article

Relapse of skin thickening after discontinuation or decrease of azathioprine therapy in a patient with diffuse cutaneous systemic sclerosis.

Published in:

Rheumatology, 2007, v. 46, n. 12, p. 1862, doi. 10.1093/rheumatology/kem272

By:

A. Scheja;
R. Hesselstrand;
M. Wildt;
A. Åkesson

Publication type:

Article

Adherence to immunosuppressant drugs in patients with connective tissue diseases.

Published in:

Rheumatology, 2007, v. 46, n. 12, p. 1859, doi. 10.1093/rheumatology/kem267

By:

D. Pyne;
K. Chaabo

Publication type:

Article

Comment on: Failure of anti-TNF therapy in TNF Receptor 1-Associated Periodic Syndrome (TRAPS).

Published in:

Rheumatology, 2007, v. 46, n. 12, p. 1865, doi. 10.1093/rheumatology/kem231

By:

E. Drewe;
R.J. Powell;
E.M. McDermott

Publication type:

Article

Anti-fibroblast antibodies detected by cell-based ELISA in systemic sclerosis enhance the collagenolytic activity and matrix metalloproteinase-1 production in dermal fibroblasts.

Published in:

Rheumatology, 2007, v. 46, n. 12, p. 1779, doi. 10.1093/rheumatology/kem241

By:

S. Fineschi;
F. Cozzi;
D. Burger;
J.-M. Dayer;
P. L. Meroni;
C. Chizzolini

Publication type:

Article

The role of HLA-DRB1 shared epitope alleles in predicting short-term response to leflunomide in rheumatoid arthritis.

Published in:

Rheumatology, 2007, v. 46, n. 12, p. 1842, doi. 10.1093/rheumatology/kem278

By:

G. Saruhan-Direskeneli;
M. Inanc;
I. Fresko;
N. Akkoc;
E. Dalkilic;
E. Erken;
Y. Karaaslan;
G. Kinikli;
F. Oksel;
S. Pay;
E. Yucel;
S. P. Yentür;
J. Duymaz-Tozkir;
V. Yilmaz;
N. Inanc;
H. Yazici;
M. Konice;
H. Direskeneli

Publication type:

Article

Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients.

Published in:

Rheumatology, 2007, v. 46, n. 12, p. 1769, doi. 10.1093/rheumatology/kem234

By:

E. Anitua;
M. Sánchez;
A. T. Nurden;
M. M. Zalduendo;
M. de la Fuente;
J. Azofra;
I. Andía

Publication type:

Article

A population-based assessment of systemic lupus erythematosus incidence and prevalence results and implications of using administrative data for epidemiological studies.

Published in:

Rheumatology, 2007, v. 46, n. 12, p. 1814, doi. 10.1093/rheumatology/kem233

By:

S. Bernatsky;
L. Joseph;
C. A. Pineau;
R. Tamblyn;
D. E. Feldman;
A. E. Clarke

Publication type:

Article

Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammation.

Published in:

Rheumatology, 2007, v. 46, n. 12, p. 1773, doi. 10.1093/rheumatology/kem222

By:

C. E. Vergunst;
D. M. Gerlag;
H. Dinant;
L. Schulz;
M. Vinkenoog;
T. J. M. Smeets;
M. E. Sanders;
K. A. Reedquist;
P. P. Tak

Publication type:

Article

Blockade of tumour necrosis factor-{alpha} in rheumatoid arthritis: effects on components of rheumatoid cachexia.

Published in:

Rheumatology, 2007, v. 46, n. 12, p. 1824, doi. 10.1093/rheumatology/kem291

By:

G. S. Metsios;
A. Stavropoulos-Kalinoglou;
K. M. J. Douglas;
Y. Koutedakis;
A. M. Nevill;
V. F. Panoulas;
M. Kita;
G. D. Kitas

Publication type:

Article

DNA hypomethylation is crucial for apoptotic DNA to induce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice.

Published in:

Rheumatology, 2007, v. 46, n. 12, p. 1796, doi. 10.1093/rheumatology/kem275

By:

Z. K. Wen;
W. Xu;
L. Xu;
Q. H. Cao;
Y. Wang;
Y. W. Chu;
S. D. Xiong

Publication type:

Article

Hospitalizations and mortality in systemic sclerosis: results from the Nationwide Inpatient Sample.

Published in:

Rheumatology, 2007, v. 46, n. 12, p. 1808, doi. 10.1093/rheumatology/kem273

By:

L. Chung;
E. Krishnan;
E. F. Chakravarty

Publication type:

Article

Five-year outcome of a primary-care-based inception cohort of patients with inflammatory polyarthritis plus psoriasis.

Published in:

Rheumatology, 2007, v. 46, n. 12, p. 1819, doi. 10.1093/rheumatology/kem270

By:

C. Morgan;
M. Lunt;
D. Bunn;
D. G. I. Scott;
D. P. M. Symmons

Publication type:

Article

Polymorphisms in the ficolin 1 gene (FCN1) are associated with susceptibility to the development of rheumatoid arthritis.

Published in:

Rheumatology, 2007, v. 46, n. 12, p. 1792, doi. 10.1093/rheumatology/kem266

By:

B. Vander Cruyssen;
L. Nuytinck;
L. Boullart;
D. Elewaut;
W. Waegeman;
M. Van Thielen;
E. De Meester;
K. Lebeer;
R. Rossau;
F. De Keyser

Publication type:

Article

Vascular pathology and osteoarthritis.

Published in:: Rheumatology, 2007, v. 46, n. 12, p. 1763, doi. 10.1093/rheumatology/kem191
Publication type:: Article

Tophaceous joint disease strongly predicts hand function in patients with gout.

Published in:

Rheumatology, 2007, v. 46, n. 12, p. 1804, doi. 10.1093/rheumatology/kem246

By:

N. Dalbeth;
J. Collis;
K. Gregory;
B. Clark;
E. Robinson;
F. M. McQueen

Publication type:

Article

Ocular manifestations of systemic lupus erythematosus.

Published in:

Rheumatology, 2007, v. 46, n. 12, p. 1757, doi. 10.1093/rheumatology/kem173

By:

R. R. Sivaraj;
O. M. Durrani;
A. K. Denniston;
P. I. Murray;
Caroline Gordon

Publication type:

Article